Joint effects of ALT level and chronic conditions were demonstrated by significant combined associations of ALT > 40 U/L and NAFLD, liver cirrhosis, HBV and HCV infection, or any one of CLDs with HCC risk. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.